Diligence memo · auto-generated · as of July 2, 2026
Sterile State, Inc.
Sterile State, Inc. looks over-valued against its niche peers and is quiet on financing cadence.
Businessfiled
Sterile State, Inc. operates in Other Health Care, based in FARMINGTON HILLS.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Sterile State, Inc. has raised $3.2M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.2M on 2025-01-07.
Most recent recorded round closed around 2025-01-07.
Valuation (modeled)modeled
Provath models Sterile State, Inc. at approximately $11M (range $2.7M–$26M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 2.70× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 18 mo ago; this sector typically re-raises about every 14 months.
Slightly overdue versus sector cadence.
Comparablesmixed
Capital scale ranks ahead of 56% of Other Health Care peers (5377 compared).
Modeled value ranks above 37% of those peers.
Closest niche peers: Xymogen, Inc., Willow Life Sciences, Inc., ManyClicks, Inc., Limber Prosthetics, Inc., Othership Inc..
Peoplefiled
7 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.